por
Sean Ruck, Contributing Editor | March 20, 2015
From the March 2015 issue of HealthCare Business News magazine
There will be greater emphasis on ambulatory CV medicine, prevention, population health outcomes, public reporting, and transparency. Genotype-phenotype correlations will become more commonplace as access to libraries of genetic information and clinical data repositories improves at the local level. EHRs may transform much of what we do. There will always be a role for imaging, interventional and EP expertise, though the numbers may change.
Lastly, however, we can never lose sight of our roles as healers, patient advocates, and clinical experts who are able to synthesize information of various types to arrive at integrated decisions in our patients’ best interests.
Back to HCB News
Ad Statistics
Times Displayed: 2147
Times Visited: 10 Fast-moving cardiac structures have a big impact on imaging. Fujifilm’s SCENARIA View premium performance CT brings solutions to address motion in Coronary CTA while delivering unique dose saving and workflow increasing benefits.
